Bendamustine in Combination With Rituximab as a First-line Therapy Followed by Maintenance Therapy With Rituximab in Patients With Follicular Lymphoma

NCT02423837 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

NETWORK

Sponsor class

Conditions

Follicular Lymphoma

Interventions

DRUG: Rituximab, bendamustine

Sponsor

National Research Center for Hematology, Russia